Your browser doesn't support javascript.
loading
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents.
Zarkoob, Hoda; Allué-Guardia, Anna; Chen, Yu-Chi; Garcia-Vilanova, Andreu; Jung, Olive; Coon, Steven; Song, Min Jae; Park, Jun-Gyu; Oladunni, Fatai; Miller, Jesse; Tung, Yen-Ting; Kosik, Ivan; Schultz, David; Iben, James; Li, Tianwei; Fu, Jiaqi; Porter, Forbes D; Yewdell, Jonathan; Martinez-Sobrido, Luis; Cherry, Sara; Torrelles, Jordi B; Ferrer, Marc; Lee, Emily M.
Afiliação
  • Zarkoob H; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Allué-Guardia A; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Chen YC; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Garcia-Vilanova A; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Jung O; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Coon S; Biomedical Ultrasonics & Biotherapy Laboratory, Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Headington, UK.
  • Song MJ; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
  • Park JG; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Oladunni F; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Miller J; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Tung YT; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
  • Kosik I; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Schultz D; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Iben J; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Li T; National Institute for Allergies and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Fu J; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, USA.
  • Porter FD; High Throughput Screening Core, University of Pennsylvania, Philadelphia, PA, USA.
  • Yewdell J; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
  • Martinez-Sobrido L; Molecular Genomics Core, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD, USA.
  • Cherry S; 3D Tissue Bioprinting Lab, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
  • Torrelles JB; Section on Molecular Dysmorphology, Division of Translational Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, 20892, USA.
  • Ferrer M; National Institute for Allergies and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Lee EM; Host-Pathogen Interactions and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Commun Biol ; 5(1): 810, 2022 08 12.
Article em En | MEDLINE | ID: mdl-35962146

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza A / Influenza Humana / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Commun Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos